Skip to main content
OpenTrials

Clinical trial condition

Cutaneous Melanoma

Explore clinical trials studying Cutaneous Melanoma. Study availability and eligibility vary by location and protocol.

58 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Cutaneous Melanoma trial results

Completed

A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas

NCT04551352

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +16 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
  • Thomas Jefferson University Hospital;Medical Oncology Philadelphia, Pennsylvania, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
View all 14 locations
View Trial Details
Completed

Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine

NCT03633110

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • John Wayne Cancer Institute - Providence Saint John's Health Center Santa Monica, California, United States
  • University of Colorado, Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma

NCT02129075

Conditions
Cutaneous Melanoma, Eye Diseases, Eye Neoplasms, +25 more
Locations
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone New York, United States
  • Mount Sinai Hospital New York, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details

Related conditions